| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Gynecology and Obstetrics, University of Freiburg, D-7800 Freiburg, Federal Republic of Germany
Epidermal growth factor (EGF)-like factors with EGF competing and cell growth stimulating activity were investigated in malignant and non-malignant tissues. About 37% of ovarian carcinomas present an increased factor activity between 9.0 and 19.3 ng EGF units/mg protein. In one tumor 175.0 ng EGF units/mg protein were found. In extracts of non-malignant tissues, the factor concentration was about 1.0–6.4 ng EGF units/mg protein. Isoelectric focusing was performed to characterize these factors. In normal ovaries and ovarian carcinomas, factors with EGF competing activity focus at pH 8.0–9.0, pH 5.7–6.3, and pH 3.6–4.9. In ovarian carcinomas, an additional peak with EGF competing and cell growth stimulating activity was found between pH 6.5 and 7.2. Similar results could be achieved in other malignant tissues investigated. These data indicate the presence of EGF-like factors. EGF itself focuses at pH 4.6 (G. Carpenter and S. Cohen, Annu. Rev. Biochem., 48: 193–216, 1979).
Specific EGF binding was determined in 12 ovarian carcinomas. In five of these cases EGF receptors could be detected. In the EGF receptor positive carcinomas, the content of EGF-like growth factors varied between 0 and 9 ng EGF units/mg protein. In EGF receptor negative cases, the content of EGF-like growth factors varied between 0 and 19.3 ng EGF units/mg protein. The clinical data of 19 patients are also demonstrated.
Received 3/13/85. Revised 12/30/85. Accepted 1/30/86.
This article has been cited by other articles:
|
|
 |
|
  A. Psyrri, M. Kassar, Z. Yu, A. Bamias, P. M. Weinberger, S. Markakis, D. Kowalski, R. L. Camp, D. L. Rimm, and M. A. Dimopoulos Effect of Epidermal Growth Factor Receptor Expression Level on Survival in Patients with Epithelial Ovarian Cancer Clin. Cancer Res., December 15, 2005; 11(24): 8637 - 8643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. del Carmen, I. Rizvi, Y. Chang, A. C. E. Moor, E. Oliva, M. Sherwood, B. Pogue, and T. Hasan Synergism of Epidermal Growth Factor Receptor-Targeted Immunotherapy With Photodynamic Treatment of Ovarian Cancer In Vivo J Natl Cancer Inst, October 19, 2005; 97(20): 1516 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Alper, E. S. Bergmann-Leitner, T. A. Bennett, N. F. Hacker, K. Stromberg, and W. G. Stetler-Stevenson Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma Cells J Natl Cancer Inst, September 19, 2001; 93(18): 1375 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Coppola, E. Catalano, and S. V. Nicosia Transforming Growth Factor-alpha and c-erbB-2 Oncogene Products in Ovarian Epithelial Tumors International Journal of Surgical Pathology, January 1, 1996; 4(3): 129 - 135. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Berchuck, A. Elbendary, L. Havrilesky, G. C. Rodriguez, and R. C. Bast Pathogenesis of Ovarian Cancers Reproductive Sciences, July 1, 1994; 1(3): 181 - 190. [Abstract] [PDF]
|
|
|
|
 |
|
 T. W. Grunt, C. Somay, H. Oeller, E. Dittrich, and C. Dittrich Comparative analysis of the effects of dimethyl sulfoxide and retinoic acid on the antigenic pattern of human ovarian adenocarcinoma cells J. Cell Sci., October 1, 1992; 103(2): 501 - 509. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
